Riverlane are teaming with AstraZeneca to understand which stages of the Computer Aided Drug Design (CADD) process would most benefit from a quantum computer’s ability to perform complex calculations and simulations. As well as understanding which stages to address, Riverlane is determining the computing resources required to perform the calculations and when the benefits are likely to be delivered. This project is a joint effort by Riverlane and AstraZeneca.